These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36158220)

  • 21. Arecoline Is Associated With Inhibition of Cuproptosis and Proliferation of Cancer-Associated Fibroblasts in Oral Squamous Cell Carcinoma: A Potential Mechanism for Tumor Metastasis.
    Li J; Chen S; Liao Y; Wang H; Zhou D; Zhang B
    Front Oncol; 2022; 12():925743. PubMed ID: 35875097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cuproptosis, the novel therapeutic mechanism for heart failure: a narrative review.
    Yuan HJ; Xue YT; Liu Y
    Cardiovasc Diagn Ther; 2022 Oct; 12(5):681-692. PubMed ID: 36329965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pan-cancer profiles of the cuproptosis gene set.
    Liu H
    Am J Cancer Res; 2022; 12(8):4074-4081. PubMed ID: 36119826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Both GLS silencing and GLS2 overexpression synergize with oxidative stress against proliferation of glioma cells.
    Martín-Rufián M; Nascimento-Gomes R; Higuero A; Crisma AR; Campos-Sandoval JA; Gómez-García MC; Cardona C; Cheng T; Lobo C; Segura JA; Alonso FJ; Szeliga M; Albrecht J; Curi R; Márquez J; Colquhoun A; Deberardinis RJ; Matés JM
    J Mol Med (Berl); 2014 Mar; 92(3):277-90. PubMed ID: 24276018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel risk model based on cuproptosis-related lncRNAs predicted prognosis and indicated immune microenvironment landscape of patients with cutaneous melanoma.
    Zhou Y; Shu Q; Fu Z; Wang C; Gu J; Li J; Chen Y; Xie M
    Front Genet; 2022; 13():959456. PubMed ID: 35938036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HDAC4-mediated Deacetylation of Glutaminase Facilitates Glioma Stemness.
    Xu G; Qu J; Zhang M
    Curr Cancer Drug Targets; 2023; 23(9):742-750. PubMed ID: 36999421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comprehensive analysis and validation of cuproptosis-associated genes across cancers: Overall survival, the tumor microenvironment, stemness scores, and drug sensitivity.
    Liu J; Lu Y; Dai Y; Shen Y; Zeng C; Liu X; Yu H; Deng J; Lu W
    Front Genet; 2022; 13():939956. PubMed ID: 36105090
    [No Abstract]   [Full Text] [Related]  

  • 28. Comprehensive multiomics analysis of cuproptosis-related gene characteristics in hepatocellular carcinoma.
    Fu J; Wang S; Li Z; Qin W; Tong Q; Liu C; Wang Z; Liu Z; Xu X
    Front Genet; 2022; 13():942387. PubMed ID: 36147507
    [No Abstract]   [Full Text] [Related]  

  • 29. A novel defined cuproptosis-related gene signature for predicting the prognosis of lung adenocarcinoma.
    Zhang H; Shi Y; Yi Q; Wang C; Xia Q; Zhang Y; Jiang W; Qi J
    Front Genet; 2022; 13():975185. PubMed ID: 36046242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and immunological characterization of cuproptosis-related molecular clusters in Alzheimer's disease.
    Lai Y; Lin C; Lin X; Wu L; Zhao Y; Lin F
    Front Aging Neurosci; 2022; 14():932676. PubMed ID: 35966780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progress in the research of cuproptosis and possible targets for cancer therapy.
    Wang J; Luo LZ; Liang DM; Guo C; Huang ZH; Sun GY; Wen J
    World J Clin Oncol; 2023 Sep; 14(9):324-334. PubMed ID: 37771632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circ-CREBBP promotes cell tumorigenesis and glutamine catabolism in glioma by regulating miR-375/glutaminase axis.
    Zhang L; Ye L; Xu Z; Jin Y; Song D
    Brain Res; 2022 Jan; 1775():147730. PubMed ID: 34813772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Copper homeostasis and cuproptosis in health and disease.
    Chen L; Min J; Wang F
    Signal Transduct Target Ther; 2022 Nov; 7(1):378. PubMed ID: 36414625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.
    Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P
    Front Immunol; 2022; 13():919231. PubMed ID: 35967366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cuproptosis-Related lncRNAs are Biomarkers of Prognosis and Immune Microenvironment in Head and Neck Squamous Cell Carcinoma.
    Yang L; Yu J; Tao L; Huang H; Gao Y; Yao J; Liu Z
    Front Genet; 2022; 13():947551. PubMed ID: 35938003
    [No Abstract]   [Full Text] [Related]  

  • 36. The prognostic value and immune landscape of a cuproptosis-related lncRNA signature in head and neck squamous cell carcinoma.
    Li YJ; Li HY; Zhang Q; Wei SL
    Front Genet; 2022; 13():942785. PubMed ID: 35942287
    [No Abstract]   [Full Text] [Related]  

  • 37. Molecular Subtyping Based on Cuproptosis-Related Genes and Characterization of Tumor Microenvironment Infiltration in Kidney Renal Clear Cell Carcinoma.
    Ji ZH; Ren WZ; Wang HQ; Gao W; Yuan B
    Front Oncol; 2022; 12():919083. PubMed ID: 35875087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Novel Inflammatory lncRNAs Prognostic Signature for Predicting the Prognosis of Low-Grade Glioma Patients.
    Xiang Z; Chen X; Lv Q; Peng X
    Front Genet; 2021; 12():697819. PubMed ID: 34408772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel cuproptosis-related gene signature for predicting prognosis in cervical cancer.
    Lei L; Tan L; Sui L
    Front Genet; 2022; 13():957744. PubMed ID: 36092887
    [No Abstract]   [Full Text] [Related]  

  • 40. A Newly Established Cuproptosis-Associated Long Non-Coding RNA Signature for Predicting Prognosis and Indicating Immune Microenvironment Features in Soft Tissue Sarcoma.
    Han J; Hu Y; Liu S; Jiang J; Wang H
    J Oncol; 2022; 2022():8489387. PubMed ID: 35847354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.